Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (2)
  • 2024 (4)
  • 2023 (2)
  • 2022 (2)
  • 2021 (2)

Subject

  • Drug Trafficking (125)
  • Synthetic drugs (113)
  • Arrests/Convictions - Major (85)
  • Overdose (43)
  • Guns/Weapons (29)
  • Guilty Plea (28)
  • Seizures (Drugs/Property) (28)
  • Fake Pills (22)
  • Prescription Drugs (18)
  • Major Law Enforcement Operation (17)
  • OCDETF/Task Force (17)
  • Money Laundering (13)
  • Take Back Day (13)
  • Extraditions (12)
  • Diversion Division (10)
  • Gangs (9)
  • Outreach/Drug Prevention (6)
  • Task Forces/Task Force Officers (6)
  • Prevention/Education - DEA websites GSAD, JTT etc (3)
  • Dark Web- Internet Trafficking (2)
  • Fentanyl Awareness (2)
  • Asset Forfeiture (1)
  • Congressional Affairs (1)
  • HIDTA (1)
  • Intergovernmental Affairs (1)
  • Narcoterrorism (1)
  • Red Ribbon (1)
  • Terrorism (1)
  • Pharmaceuticals/Pharmacists/Physicians (12)

Drug Name

  • Opioids (4)
  • Oxycodone (2)

Field Division

  • Washington, DC (35)
  • St. Louis (32)
  • New York (21)
  • Chicago (19)
  • Miami (16)
  • Atlanta (12)
  • New Jersey (11)
  • El Paso (9)
  • Sede (9)
  • Dallas (8)
  • Houston (7)
  • Seattle (7)
  • Louisville (5)
  • New England (5)
  • Los Angeles (4)
  • New Orleans (4)
  • Rocky Mountain (3)
  • Omaha (2)
  • Phoenix (2)
  • Philadelphia (1)
  • San Francisco (7)
  • San Diego (5)
Clear All Results
PRESS RELEASE

Digital Health Company Cofounder/CEO and Clinical President Convicted in $100M Adderall Distribution and Health Care Fraud Scheme

Noviembre 20, 2025
SAN FRANCISCO – United States Drug Enforcement Administration (“DEA”) San Francisco Division Special Agent in Charge Bob Beris, DEA New York Division Special Agent in Charge Frank Tarentino, along with our law enforcement partners Homeland Security Investigations (“HSI”) , U.S. Department of Health and Human Services – Office of Inspector...
Noviembre 20, 2025
PRESS RELEASE

DEA Hosts the 29th National Prescription Drug Take Back Day on Saturday, October 25th

Octubre 22, 2025
SAN FRANCISCO – The Drug Enforcement Administration, in collaboration with nearly 4,000 law enforcement partners across the country, will host the 29th National Prescription Drug Take Back Day this Saturday, October 25, from 10 a.m. to 2 p.m. At nearly 4,000 collection sites throughout the United States, DEA’s National Prescription...
Octubre 22, 2025
PRESS RELEASE

Madera Pharmacist Sentenced to over 7 Years in Prison for Illegally Trafficking Hundreds of Thousands of Opiate Pills

Noviembre 25, 2024
FRESNO, Calif. — Ifeanyi Vincent Ntukogu, 49, of Fresno, was sentenced today to seven years and three months in prison for illegally distributing oxycodone and hydrocodone. Ntukogu was a pharmacist in Madera who dispensed more than 450,000 oxycodone and hydrocodone pills based on fraudulent prescriptions, all in exchange for cash...
Noviembre 25, 2024
PRESS RELEASE

OptumRx Agrees to Pay $20M to Resolve Allegations that It Filled Opioid Prescriptions in Violation of the Controlled Substances Act

Junio 27, 2024
SAN DIEGO – OptumRx Inc., a prescription drug benefit provider, has agreed to pay $20 million to resolve allegations that it improperly filled certain opioid prescriptions in violation of the Controlled Substances Act. The settlement resolves an investigation initiated by the Drug Enforcement Administration (DEA) into whether, between April 2013...
Junio 27, 2024
PRESS RELEASE

Palomar Hospital Pays $250,000 for Diverting Fentanyl

Junio 03, 2024
SAN DIEGO – Palomar Health, a California public health care district located in San Diego County, has paid $250,000 to resolve allegations of diversion of fentanyl from one of its facilities and failure to keep accurate records for fentanyl. Palomar Health is California’s largest health care district, with campuses in...
Junio 03, 2024
PRESS RELEASE

East Bay Doctor Sentenced to Prison for Distributing Opioids Outside the Scope of Medical Practice

Marzo 18, 2024
OAKLAND, Calif. – Parto Karimi, a former Bay Area doctor, has been sentenced to one year and one day in federal prison for distributing powerful opioids outside the scope of medical practice, announced United States Attorney Ismail J. Ramsey and Drug Enforcement Administration (DEA), San Francisco Field Division, Special Agent...
Marzo 18, 2024
PRESS RELEASE

Federal Court Shuts Down San Joaquin County Pharmacy and Orders $1 Million in Civil Penalties

Noviembre 14, 2023
SACRAMENTO, Calif. — Nor-Cal Pharmacies Inc., doing business as Lockeford Drug, and pharmacist/owner Lawrence Howen have agreed to pay $1 million in penalties to resolve allegations of violations of the Controlled Substances Act, U.S. Attorney Phillip A. Talbert and Drug Enforcement Administration Special Agent in Charge Brian M. Clark announced...
Noviembre 14, 2023
PRESS RELEASE

San Jose Doctor Convicted of Twelve Counts of Illegally Prescribing Opioids

Junio 22, 2023
SAN JOSE, Calif. – A federal jury yesterday convicted family medicine physician Donald Siao of twelve counts of distributing the controlled substances Oxycodone and Hydrocodone outside the scope of his usual professional practice and without a legitimate medical purpose, announced United States Attorney Ismail J. Ramsey, Drug Enforcement Administration (DEA)...
Junio 22, 2023
PRESS RELEASE

Doctor and Office Manager Indicted in Scheme to Defraud Medicare, Manufacture and Distribute Fentanyl

Diciembre 16, 2022
SAN DIEGO - Dr. David J. Smith, a pain management physician, and his office manager, Julia Ann Oertle, are charged in a federal grand-jury indictment with perpetuating a long-running scheme to commit healthcare fraud and to manufacture and distribute adulterated fentanyl. Smith made his initial appearance today before U.S. Magistrate...
Diciembre 16, 2022
PRESS RELEASE

San Diego Pharmacy Pays $105,000 Penalty for Illegitimately Dispensing Opioids

Enero 20, 2022
SAN DIEGO – San Diego’s Balboa Pharmacy has paid $105,000 to resolve allegations that it illegally dispensed opioids and other dangerous drugs to its patients, according to a settlement agreement signed by Balboa Pharmacy and the United States. The settlement stems from the United States’ continued efforts to combat the...
Enero 20, 2022
Showing 1 - 10 of 12 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster